Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials

Experimental therapeutic oncology agents are often combined to circumvent tumor resistance to individual agents. However, most combination trials fail to demonstrate sufficient safety and efficacy to advance to a later phase. This study collected survey data on phase 1 combination therapy trials ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Paller, Channing J., Huang, Erich P., Luechtefeld, Thomas, Massett, Holly A., Williams, Christopher C., Zhao, Jinxiu, Gravell, Amy E., Tamashiro, Tami, Reeves, Steven A., Rosner, Gary L., Carducci, Michael A., Rubinstein, Lawrence, Ivy, S. Percy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558040/
https://www.ncbi.nlm.nih.gov/pubmed/31214592
http://dx.doi.org/10.3389/fmed.2019.00122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558040/
https://www.ncbi.nlm.nih.gov/pubmed/31214592
http://dx.doi.org/10.3389/fmed.2019.00122

Ejemplares similares